Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $69.30 million as of August 15, 2025. Its market cap has increased by 140.12% in one year.

Market Cap

69.30M

Enterprise Value

68.78M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.60

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 69.30M, an increase of 904.91%. That is a compound annual growth rate of 7.99%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	69.30M	128.54%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.93M
Veradigm	781.22M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	580.89M
Glass House Brands	567.91M
American Oncology Network	379.23M
Northwest Biotherapeutics	363.17M
CytoDyn	344.75M

Market Cap Rankings